Anifrolumab
id:
anifrolumab-254-11851242
title:
Anifrolumab
text:
Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β. Anifrolumab was approved for medical use in the United States in July 2021, and in the European Union in February 2022. The U.S. Food and Drug Administration considers it to be a first-in-class medication.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Anifrolumab
date created:
date modified:
2024-03-26T05:37:35Z
main entity:
{"identifier":"Q15708296","url":"https://www.wikidata.org/entity/Q15708296"}
image:
fields total:
13
integrity:
14